Dr. Joseph P. Farrell
July 9, 2016
By now you may have heard about the merger plans of German chemicals giant Bayer, which wants to buy Mon(ster)santo. Birds of a feather flock together, as the old saying goes, so I suppose there’s nothing newsworthy about a former charter company of I.G. Farben wanting to buy an American corporation with a similar track record. But part of the plan appears to be that these two GMO giants want to control the marijuana trade (nothing like that good olde “bottom line”), in these articles shared by Ms. M.W>:
As the War on Weed Winds Down, Will Monsanto Be the Big Winner?
The War on Weed Part II: Monsanto, Bayer, and the Push for Corporate Cannabis
As the authoress of the article, Ellen Brown, notes, cannabis and hemp were used not only as a primary argircultural crop prior to the “war on weed,” but were components of various medicines, and it is now acknowledged that the plant has beneficial medical uses:
Cannabis is actually one of the oldest domesticated crops, having been grown for industrial and medicinal purposes for millennia. Until 1883, hemp was also one of the largest agricultural crops (some say the largest). It was the material from which most fabric, soap, fuel, paper and fiber were made. Before 1937, it was also a component of at least 2,000 medicines.
So why the rush of Bayer, the German GMO-chemical-pharmaceutical giant, and Mon(ster)santo – IG Farbensanto as I like to call it – to enter the cannabis market? Predictably, it’s about patents and profits:
Continue Reading At: GizaDeathStar.com